Financial Ratios

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE391.108 (+2.09 %)
PREV CLOSE ( ) 383.10
OPEN PRICE ( ) 377.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12633
TODAY'S LOW / HIGH ( )377.75 393.00
52 WK LOW / HIGH ( )306.1 401
NSE391.258 (+2.09 %)
PREV CLOSE( ) 383.25
OPEN PRICE ( ) 384.50
BID PRICE (QTY) 391.25 (1166)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 332051
TODAY'S LOW / HIGH( ) 382.10 393.70
52 WK LOW / HIGH ( )309.1 401
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.892.75-15.28-6.010.82
   CEPS(Rs)9.289.11-8.372.946.19
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)81.4578.4869.6568.4972.70
   Tax Rate(%)30.2552.806.5918.5842.34
Margin Ratios
   Core EBITDA Margin(%)16.8117.2812.0716.8114.69
   EBIT Margin(%)9.8614.57-23.352.559.43
   Pre Tax Margin(%)5.739.54-33.68-9.511.96
   PAT Margin (%)4.004.50-31.46-7.741.13
   Cash Profit Margin (%)12.8414.90-17.243.798.50
Performance Ratios
   ROA(%)2.382.40-11.61-3.380.58
   ROE(%)3.613.90-25.87-8.551.16
   ROCE(%)8.0210.46-12.551.626.13
   Asset Turnover(x)0.600.530.370.440.51
   Sales/Fixed Asset(x)0.820.760.550.751.00
   Working Capital/Sales(x)6.636.027.80-2.92-4.71
Efficiency Ratios
   Fixed Capital/Sales(x)1.221.311.811.331.00
   Receivable days67.6366.0889.8678.9977.45
   Inventory Days6.996.287.337.659.53
   Payable days158.60154.13237.82255.84262.80
Valuation Parameters
   PER(x)90.9398.080.000.00261.38
   PCE(x)28.2929.63-22.8225.4834.80
   Price/Book(x)3.233.442.741.102.96
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.684.404.301.653.60
   EV/Core EBITDA(x)19.3423.4826.888.9021.45
   EV/EBIT(x)37.2930.20-18.4364.8938.22
   EV/CE(x)2.923.102.251.032.16
   M Cap / Sales3.634.413.930.972.96
Growth Ratio
   Net Sales Growth(%)18.3339.58-11.557.479.25
   Core EBITDA Growth(%)19.9663.40-23.7418.862.77
   EBIT Growth(%)-19.97187.09-911.00-70.96-5.17
   PAT Growth(%)5.07119.97-259.40-835.64-70.89
   EPS Growth(%)4.99118.01-154.27-829.20-71.23
Financial Stability Ratios
   Total Debt/Equity(x)0.110.100.270.800.66
   Current Ratio(x)1.691.661.310.500.63
   Quick Ratio(x)1.591.581.270.480.58
   Interest Cover(x)2.392.89-2.260.211.26
   Total Debt/Mcap(x)0.030.030.100.730.22

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.